#AI--RxUtility, the medication affordability platform, today announced the beta launch of Mimi™, the healthcare industry’s most comprehensive AI companion to help people navigate the full range of...

For the first time, consumers can discuss all prescription cost options using a simple, conversational experience built as infrastructure, not just a savings app
NASHVILLE, Tenn.: #AI--RxUtility, the medication affordability platform, today announced the beta launch of Mimi™, the healthcare industry’s most comprehensive AI companion to help people navigate the full range of medication cost options. Free for everyone to use during the beta period, Mimi guides consumers through a personalized conversation to ensure they have every available option in front of them. Users make AI-informed decisions with confidence, based on their insurance coverage, location, and budget.
Try Mimi for free at: https://getmimi.ai
“There has been progress in lowering prices for some drugs, but consumers are more confused than ever on what is actually the lowest cost option for them,” said Miriam Paramore, CEO of RxUtility. “Mimi walks each person through every price and discount option-literally every price at every pharmacy. That means no more guesswork and no more abandoned prescriptions because a consumer didn't know a better price existed.”
Mimi is trained on the full universe of prescription drug reference data and the available prices for all prescription medications across all U.S. pharmacies. The secure, AI experience works by asking a few simple questions, such as medication name, dosage, and insurance coverage to engage consumers in a conversation to surface the lowest price options for their unique situation. Mimi then compares prices across nearby geo-located pharmacies, insurance estimates, pharma copay coupon savings and the best cash discount.
Nearly 98 million prescriptions are abandoned each year due to cost surprises. A recent KFF study showed more than four in ten adults (43%) report they have not taken their medication as prescribed at some point in the past year because of transparency issues about pricing. And 6 out of 10 Americans are worried about medication costs-a record high. RxUtility's proprietary knowledge base aggregates billions in savings annually, and now providers, pharmacies, self-insured employers, payers and other digital health providers can embed Mimi into their platforms or offer it directly to the people they serve.
Key features include:
"When people understand their price options upfront, they're more confident, more likely to start therapy, and more likely to stick with the medications they need for their health," Paramore said. "That kind of transparency has never been available, and now organizations can deploy it effortlessly. Everyone wins."
About RxUtility
RxUtility provides AI-native technology purpose-built to make medications affordable for consumers. RxUtility is the only company to connect providers, pharmacists, employers, payers and digital health partners with real-time access to all medication prices through its affordability platform. By embedding prescription affordability and transparency in these tech workflows, RxUtility reduces patient payment confusion, drives medication adherence and ensures equitable access to prescription drugs. Learn more at www.rxutility.com.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
NCR Atleos Corporation (NYSE: NATL) (“Atleos”) will release first quarter 2026 financial results after the market close on Wednesday, May 6, 2026. Due…
Nebius Group N.V. (“Nebius Group” or the “Company”; NASDAQ: NBIS), will release its first quarter 2026 financial results on Wednesday, May 13, 2026, before…
General Analysis, a company building security infrastructure for agentic AI, today announced $10 million in seed funding led by Altos Ventures, with participation…
Extreme Networks, Inc. (“Extreme”) (Nasdaq: EXTR) today released financial results for its third quarter of fiscal 2026 ended March 31, 2026. “Our fifth…